BioCentury
ARTICLE | Clinical News

CAP7: Preliminary Phase II data

February 8, 2016 8:00 AM UTC

Preliminary data from 18 patients with adenocarcinoma arising from bile ducts or the gallbladder in an open-label, German Phase II trial showed that 150 and 200 mg/m 2 CAP7.1 on days 1-5 of a 21-day c...